As of 2024-12-15, the EV/EBITDA ratio of West Pharmaceutical Services Inc (WST) is 31.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WST's latest enterprise value is 23,617.02 mil USD. WST's TTM EBITDA according to its financial statements is 738.80 mil USD. Dividing these 2 quantities gives us the above WST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 19.8x | 17.2x |
| Forward P/E multiples | 19.5x - 22.9x | 21.9x |
| Fair Price | 139.42 - 326.88 | 246.10 |
| Upside | -57.8% - -1.0% | -25.4% |
| Date | EV/EBITDA |
| 2024-12-13 | 31.97 |
| 2024-12-12 | 32.12 |
| 2024-12-11 | 30.81 |
| 2024-12-10 | 30.91 |
| 2024-12-09 | 31.19 |
| 2024-12-06 | 31.23 |
| 2024-12-05 | 30.81 |
| 2024-12-04 | 31.09 |
| 2024-12-03 | 31.17 |
| 2024-12-02 | 31.24 |
| 2024-11-29 | 31.54 |
| 2024-11-27 | 31.31 |
| 2024-11-26 | 30.92 |
| 2024-11-25 | 30.96 |
| 2024-11-22 | 30.65 |
| 2024-11-21 | 31.07 |
| 2024-11-20 | 30.16 |
| 2024-11-19 | 29.42 |
| 2024-11-18 | 29.73 |
| 2024-11-15 | 30.44 |
| 2024-11-14 | 32.76 |
| 2024-11-13 | 33.33 |
| 2024-11-12 | 31.73 |
| 2024-11-11 | 31.72 |
| 2024-11-08 | 31.38 |
| 2024-11-07 | 31.32 |
| 2024-11-06 | 31.90 |
| 2024-11-05 | 31.32 |
| 2024-11-04 | 30.47 |
| 2024-11-01 | 30.64 |
| 2024-10-31 | 29.80 |
| 2024-10-30 | 30.30 |
| 2024-10-29 | 30.83 |
| 2024-10-28 | 30.04 |
| 2024-10-25 | 29.80 |
| 2024-10-24 | 32.03 |
| 2024-10-23 | 27.69 |
| 2024-10-22 | 27.69 |
| 2024-10-21 | 27.77 |
| 2024-10-18 | 28.37 |
| 2024-10-17 | 27.91 |
| 2024-10-16 | 27.94 |
| 2024-10-15 | 28.14 |
| 2024-10-14 | 28.57 |
| 2024-10-11 | 28.52 |
| 2024-10-10 | 28.05 |
| 2024-10-09 | 27.70 |
| 2024-10-08 | 27.70 |
| 2024-10-07 | 28.08 |
| 2024-10-04 | 28.68 |